Figure 4 — Decreased TMPRSS2 expression by SARS-CoV-2 predicts the poor prognosis of lung cancer patients through metabolic pathways and immune infiltration

Research Paper|Volume 14, Issue 1|pp. 73–108

Decreased TMPRSS2 expression by SARS-CoV-2 predicts the poor prognosis of lung cancer patients through metabolic pathways and immune infiltration

Back to articleFigure 4(4 of 11)

100%

Figure 4.Establishment and validation of the prognostic nomogram. (A, B) Univariate and multivariate Cox regression analysis of clinicopathologic variables and TMPRSS2 in lung cancer. (C) Nomogram for predicting the 1-, 3-, and 5-year OS of lung cancer patients. (D) Calibration curves of 1-, 3-, and 5-year OS of lung cancer patients.